RE:RE:RE:RE:BNN Marketcalljojomarch wrote: For a few years i thought that a JV/Partnership was the perfect venue to create value for TLT and its shareholders . Eventually i realized that the management at TLT wasn't going that route because they wanted to do it alone with their own resources and i was told we had to build a foundation to get big pharma to show any interest . Now i have formulated a new opinion , we need to treat and be successful with at least one patient that has a US birth certificate in order to create fair value for our diamond in the rough of a company . Canada has the rough diamond but until it's on display in Tiffanys on 5th avenue we are not getting fair value for it .
MERRY XMAS
Well that depends on what you mean by 'value' as Clairidge has mentioned IPO of Private companies that list on Nas have to have $3 bucks..
Do you really think we will go into the USA trading on the garbage OTC with the hopes of getting serious 'analysts' to cover a stock in creating efficacy speculation?
IMO the whole sales pitch 2014-2019 (Q1-2020) is about this very thing..
Ms Lang quipped.. if it works in people in 2014
TLT has 5 patients treated in 2019 ready for 90 day efficacy (to prove the 'fix works') 6 and 12 have nothing to do with the 3 month CR 'claim' and promotion of such.
We went through countless threads Nasdaq this... yada that..
Fair value actually is in Canada playing catch up to $3 bucks which isn't even bullish... investors in the USA will be 'EARLY' getting into TLT because of 100 patients.. you're getting a great opportunity with an early Phase 2.. into the USA to really make it on '5th avenue'
Thing is all the stores on 5th avenue have a listing on Nasdaq
shrugs.... i been around this watering hole so long its sickening.
fair value is $3..... when the sales pitch of .30 to $3 occurs.
Then the US birth certificates can take us to $30++
shrugs.... maybe im super delusional...... ah well.